Educational grant support provided by:
- Allergan, Inc.
- Astellas Pharma Global Development, Inc. Medical Affairs, Americas
028IC: Contemporary Pharmacotherapy for OAB
Director: Eric S. Rovner, MD
Faculty: Christopher R. Chapple, BSc, MD, DHC, FRCS, FEBU
Faculty: Alan J. Wein, MD, PhD
062IC: Botulinum Toxin: Why Use It, How to Do It, What are the Results?
Director: Michael B. Chancellor, MD
OAB Shared Decision Making and Setting Expectations for Treatment